A detailed history of Alyeska Investment Group, L.P. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,867,633 shares of LIFE stock, worth $3.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,867,633
Previous 1,505,555 24.05%
Holding current value
$3.47 Million
Previous $2.94 Million 0.75%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.0 - $2.07 $0 - $749,501
362,078 Added 24.05%
1,867,633 $2.91 Million
Q1 2024

May 15, 2024

SELL
$1.42 - $2.02 $1.35 Million - $1.92 Million
-950,000 Reduced 38.69%
1,505,555 $2.94 Million
Q4 2023

Feb 14, 2024

BUY
$1.11 - $1.51 $277,500 - $377,500
250,000 Added 11.34%
2,455,555 $3.46 Million
Q2 2023

Aug 14, 2023

SELL
$1.72 - $2.57 $460,270 - $687,729
-267,599 Reduced 10.82%
2,205,555 $4.76 Million
Q1 2023

May 15, 2023

BUY
$1.88 - $2.5 $2.06 Million - $2.74 Million
1,094,407 Added 79.38%
2,473,154 $5.19 Million
Q4 2022

Feb 14, 2023

BUY
$2.02 - $2.49 $606,000 - $747,000
300,000 Added 27.81%
1,378,747 $3.02 Million
Q3 2022

Nov 14, 2022

BUY
$2.79 - $4.15 $296,914 - $441,647
106,421 Added 10.94%
1,078,747 $3.24 Million
Q2 2022

Aug 15, 2022

BUY
$2.63 - $5.61 $556,318 - $1.19 Million
211,528 Added 27.8%
972,326 $2.75 Million
Q1 2022

May 16, 2022

BUY
$4.75 - $7.54 $407,659 - $647,105
85,823 Added 12.71%
760,798 $4.07 Million
Q4 2021

Feb 14, 2022

SELL
$7.29 - $9.5 $3.02 Million - $3.93 Million
-413,689 Reduced 38.0%
674,975 $5.04 Million
Q3 2021

Nov 15, 2021

SELL
$4.22 - $12.48 $785,270 - $2.32 Million
-186,083 Reduced 14.6%
1,088,664 $9.89 Million
Q2 2021

Aug 16, 2021

BUY
$3.62 - $4.88 $1.05 Million - $1.42 Million
291,153 Added 29.6%
1,274,747 $6.22 Million
Q1 2021

May 17, 2021

BUY
$3.53 - $8.06 $497,871 - $1.14 Million
141,040 Added 16.74%
983,594 $4.38 Million
Q4 2020

Feb 16, 2021

BUY
$3.07 - $4.66 $276,017 - $418,971
89,908 Added 11.95%
842,554 $3.27 Million
Q3 2020

Nov 16, 2020

BUY
$3.23 - $5.39 $86,118 - $143,708
26,662 Added 3.67%
752,646 $2.43 Million
Q2 2020

Aug 14, 2020

SELL
$2.55 - $4.58 $31,375 - $56,352
-12,304 Reduced 1.67%
725,984 $3.22 Million
Q1 2020

May 15, 2020

BUY
$2.17 - $7.06 $1.6 Million - $5.21 Million
738,288 New
738,288 $2.07 Million

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.